Document is current
Any future updates will be listed below
-
Authors
Alameddine, Raafat
Mallea, Patrick
Shahab, Farhan
Zakharia, Yousef https://orcid.org/0000-0001-9480-2626
- License Information
-
More Information
Article History
Accepted: 24 May 2023
First Online: 5 July 2023
Declarations
:
: Grant/research support from institution clinical trial support from NewLink Genetics, Pfizer, Exelixis, and Eisai.DSMC: Janssen Research and DevelopmentConsultant honorarium: Pfizer, Novartis
: Raafat Alameddine, Patrick Mallea, and Farhan Shahab declare that they have no conflicts of interest. Yousef Zakharia has disclosed the following: Advisory Board: Bristol Myers Squibb, Amgen, Roche Diagnostics, Novartis, Janssen, Eisai, Exelixis, Castle Bioscience, Genzyme Corporation, Astrazeneca, Array, Bayer, Pfizer, Clovis, EMD serono, and Myovant.
: This article does not contain any studies with human or animal subjects performed by any of the authors
